Market Cap (In INR)
390.17 Billion
Revenue (In INR)
34.53 Billion
Net Income (In INR)
5.89 Billion
Avg. Volume
128.95 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1667.85-3088.0
- PE
- -
- EPS
- -
- Beta Value
- 0.189
- ISIN
- INE159A01016
- CUSIP
- Y2709V112
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Bhushan Akshikar
- Employee Count
- -
- Website
- https://india-pharma.gsk.com
- Ipo Date
- 2002-07-01
- Details
- GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
More Stocks
-
UREQFDevEx Resources Limited
UREQF
-
3363
-
ATAZFAtea ASA
ATAZF
-
CENTRALBKCentral Bank of India
CENTRALBK
-
ALUP3Alupar Investimento S.A.
ALUP3
-
BRPT
-
ADVWWAdvantage Solutions Inc.
ADVWW
-
TRITURBINETriveni Turbine Limited
TRITURBINE